Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$994K Sell
8,207
-23
-0.3% -$2.65K 0.04% 107
2025
Q4
$873K Buy
8,230
+3,223
+64% +$303K 0.04% 122
2025
Q3
$424K Buy
+5,007
New +$412K 0.02% 148
2024
Q3
Sell
-1,871
Closed -$233K 221
2024
Q2
$233K Buy
+1,871
New +$241K 0.01% 164
2022
Q3
Sell
-2,356
Closed -$216K 137
2022
Q2
$216K Buy
+2,356
New +$209K 0.02% 134

Other funds holding MRK

GenTrust's MRK Position: Q1 2026 in Review

GenTrust reduced its Merck (MRK) stake by 0.28% in Q1 2026, selling an estimated $2.65K and leaving 8,207 shares worth $994K. The position accounts for 0.04% of the portfolio, ranked #107.

GenTrust first reported a position in MRK in Q2 2022 and has held it in 5 quarters since. 3,775 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • GenTrust held 8,207 shares of Merck worth $994K as of Q1 2026.
  • GenTrust sold 23 Merck shares in Q1 2026, an estimated $2.65K.
  • Merck made up 0.04% of GenTrust's portfolio in Q1 2026, its #107 holding.
  • GenTrust first reported a position in Merck in Q2 2022 and has held it in 5 quarters since.
  • 3,775 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on GenTrust's 13F filing for Q1 2026, filed 27 Apr 2026.